NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-056-2011-0-AT-21 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS AT EP 12757534.8 Issued
NCI E-056-2011-0-BE-22 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS BE EP 12757534.8 Issued
NCI E-056-2011-0-FI-28 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS FI EP 12757534.8 Issued
NCI E-056-2011-0-DK-26 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS DK EP 12757534.8 Issued
NCI E-056-2011-0-DE-25 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS DE EP 12757534.8 Issued
NCI E-056-2011-0-FR-29 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS FR EP 12757534.8 Issued
NCI E-056-2011-0-EP-08 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS EP National Stage 12757534.8 Issued
NCI E-056-2011-0-AU-04 The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer AU National Stage 2012228937 Issued
NCI E-056-2011-0-JP-11 The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer JP National Stage 2013-558234 Issued
NCI E-056-2011-0-SG-15 The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer SG National Stage 2013068176 Issued
NCI E-056-2011-0-PCT-02 The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer PCT PCT PCT/US12/29636 Expired
NCI E-019-2012-0-US-01 Soluble Engineered Monomeric FC US 61/612,138 Abandoned
NCI E-056-2012-0-US-01 ZIRCONIUM-89 COMPLEXES, METHODS OF LABELING CELLS, LABELED CELLS, KITS, AND METHODS OF USE THEREOF US 61/611,964 Abandoned
NHGRI E-060-2011-0-EP-03 Methods For Treating Leukemia And Disorders Mediated By CBFBETA And RUNX1 Proteins EP National Stage 12710636.7 Issued
NHGRI E-060-2011-0-DE-05 Methods For Treating Leukemia And Disorders Mediated By CBFBETA And RUNX1 Proteins DE EP 12710636.7 Abandoned
NHGRI E-060-2011-0-GB-06 Methods For Treating Leukemia And Disorders Mediated By CBFBETA And RUNX1 Proteins GB EP 12710636.7 Abandoned
NHGRI E-060-2011-0-PCT-02 Methods For Treating Leukemia And Disorders Mediated By CBFBETA And RUNX1 Proteins PCT PCT PCT/US2012/029169 Expired
NCI E-162-2009-0-US-07 Pharmaceutical Compositions Which Inhibit FKBP52-Mediated Regulation of Androgen Receptor Function And Methods Of Using Same US National Stage 13/395,976 8859207 Abandoned PDF
CC E-063-2011-0-PCT-02 A Radiographic Marker That Displays An Angle In Degrees On Portable X-Rays PCT PCT PCT/US2012/029108 Expired
NCI E-059-2009-0-US-03 RNA Nanoparticles And Nanotubes US National Stage 13/378,935 9732337 Issued PDF
NIAMS E-073-2011-1-US-01 ANTIBODIES THAT BIND TO TL1A AND METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASE ADMINISTERING SUCH ANTIBODIES US CIP 13/419,203 9068003 Issued PDF
NIAMS E-073-2011-1-PCT-02 Blockade of TL1A-DR3 Interactions to Ameliorate T Cell Mediated Disease Pathology PCT PCT COMB PCT/US2012/028926 Expired
NIAMS E-073-2011-1-EP-05 Blockade of TL1A-DR3 Interactions to Ameliorate T Cell Mediated Disease Pathology And Antibodies Thereof EP National Stage 12790157.7 Abandoned
NIAMS E-073-2011-1-JP-06 Blockade of TL1A-DR3 Interactions to Ameliorate T Cell Mediated Disease Pathology and Antibodies Thereof JP National Stage 2014-512833 Abandoned
NIAMS E-073-2011-1-AU-03 Blockade of TL1A-DR3 Interactions to Ameliorate T Cell Mediated Disease Pathology and Antibodies Thereof AU National Stage 2012259312 Abandoned
NIAMS E-073-2011-1-CA-04 Blockade of TL1A-DR3 Interactions to Ameliorate T Cell Mediated Disease Pathology and Antibodies Thereof CA National Stage 2836898 Abandoned
NIAMS E-073-2011-1-KR-07 Blockade of TL1A-DR3 Interactions to Ameliorate T Cell Mediated Disease Pathology And Antibodies Thereof KR National Stage 10-2013-7033718 Abandoned
NHLBI E-241-2010-0-CN-08 Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery CN National Stage 201280022523.5 Issued
NCI E-285-2006-2-CA-04 DIFFERENTIAL GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL ANGIOGENESIS CA National Stage 2669260 Issued
NHLBI E-241-2010-0-AU-05 Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery AU National Stage 2012228376 Issued
NHLBI E-241-2010-0-PCT-03 Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery PCT PCT PCT/EP2012/054303 Expired
NHLBI E-241-2010-0-EP-13 Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery EP National Stage 12708035.6 Abandoned
NHLBI E-241-2010-0-EP-14 Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery EP DIV 19197891.5 Abandoned
NHLBI E-241-2010-0-JP-18 Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery JP DIV 2021-156646 Abandoned
NHLBI E-241-2010-0-JP-16 Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery JP DIV 2019-137797 Abandoned
NHLBI E-241-2010-0-JP-15 Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery JP DIV 2017-093751 Abandoned
NHLBI E-241-2010-0-JP-11 Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery JP National Stage 2013-557138 Abandoned
NHLBI E-241-2010-0-BR-06 Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery BR National Stage 1120130231858 Pending
NHLBI E-241-2010-0-IN-10 CAPSID FREE AAV VECTORS COMPOSITIONS AND METHODS FOR VECTOR PRODUCTION AND GENE DELIVERY IN National Stage 8000/DELNP/2013 Pending
NCI E-007-2011-0-PCT-02 Combination Chemotherapy For Treatment Of Cancer PCT PCT PCT/US2012/028567 Expired
NIDCR E-298-2004-0-US-04 Transcytosis of Adeno-Associated Viruses US CON 13/416,717 Abandoned
NHLBI E-243-2009-0-US-03 Method for the Treatment of Pulmonary Disease and Method of Producing Proteins of Use Therein: US National Stage 13/394,393 8828380 Issued PDF
NIDCR E-329-2003-0-US-04 Bovine Adeno-Associated Viral (BAAV) Vector And Uses Thereof US DIV 13/413,321 8685722 Abandoned PDF
CC E-160-2011-0-EP-05 System And Method For Automatic Initialization For Ultrasound Image Liver Registration EP National Stage 12713324.7 Issued
NIBIB E-078-2011-0-PCT-02 OPTOMECHANICAL MODULE FOR CONVERTING A MICROSCOPE TO PROVIDE SELECTIVE PLANE ILLUMINATION MICROSCOPY PCT PCT PCT/US2012/027524 Expired
CC E-160-2011-0-PCT-02 SYSTEM AND METHOD FOR AUTOMATED INITIALIZATION AND REGISTRATION OF NAVIGATION SYSTEM PCT PCT PCT/IB2012/050999 Expired
NCI E-132-2012-0-US-01 Altering the Immunodominance Hierarchy of HIV GAG by DNA Vaccine Expressing Conserved Regions US 61/606,265 Abandoned
NCI E-096-2011-0-PCT-02 METHOD OF SELECTING CANCER PATIENTS FOR ANTI-ANGIOGENESIS THERAPY IN COMBINATION WITH CHEMOTHERAPY PCT PCT PCT/US2012/027283 Expired
NCI E-108-2004-1-US-08 Methods For Identifying, Diagnosing, and Predicting Survival of Lymphomas US CON 13/409,416 Abandoned
NIA E-172-2009-0-US-07 Methods For Enhancing Genome Stability And Telomere Elongation In Embryonic Stem Cells US National Stage 13/393,456 8741649 Issued PDF